Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Articles by Review for PubMed (Select 10903395)

1.

The search for selective ligands for the CB2 receptor.

Huffman JW.

Curr Pharm Des. 2000 Sep;6(13):1323-37. Review.

PMID:
10903395
2.

CB2 receptor ligands.

Huffman JW.

Mini Rev Med Chem. 2005 Jul;5(7):641-9. Review.

PMID:
16026310
3.

Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor.

Marriott KS, Huffman JW.

Curr Top Med Chem. 2008;8(3):187-204. Review.

PMID:
18289088
4.

Cannabimimetic indoles, pyrroles and indenes.

Huffman JW.

Curr Med Chem. 1999 Aug;6(8):705-20. Review.

PMID:
10469887
5.

Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.

Huffman JW, Padgett LW.

Curr Med Chem. 2005;12(12):1395-411. Review.

PMID:
15974991
6.

Pharmacological actions of cannabinoids.

Pertwee RG.

Handb Exp Pharmacol. 2005;(168):1-51. Review.

PMID:
16596770
7.

Pharmacology of cannabinoid receptor ligands.

Pertwee RG.

Curr Med Chem. 1999 Aug;6(8):635-64. Review.

PMID:
10469884
8.

Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

Poso A, Huffman JW.

Br J Pharmacol. 2008 Jan;153(2):335-46. Epub 2007 Nov 5. Review.

9.

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

Ashton JC, Wright JL, McPartland JM, Tyndall JD.

Curr Med Chem. 2008;15(14):1428-43. Review.

PMID:
18537620
10.

The cannabinoid system and cytokine network.

Klein TW, Lane B, Newton CA, Friedman H.

Proc Soc Exp Biol Med. 2000 Oct;225(1):1-8. Review.

PMID:
10998193
11.

Cannabinergic ligands.

Palmer SL, Thakur GA, Makriyannis A.

Chem Phys Lipids. 2002 Dec 31;121(1-2):3-19. Review.

PMID:
12505686
12.

Medicinal chemistry endeavors around the phytocannabinoids.

Stern E, Lambert DM.

Chem Biodivers. 2007 Aug;4(8):1707-28. Review.

PMID:
17712816
13.
15.

Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands.

Raitio KH, Salo OM, Nevalainen T, Poso A, Järvinen T.

Curr Med Chem. 2005;12(10):1217-37. Review.

PMID:
15892633
16.

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.

McCarberg BH, Barkin RL.

Am J Ther. 2007 Sep-Oct;14(5):475-83. Review.

PMID:
17890938
17.

New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors.

Gertsch J, Raduner S, Altmann KH.

J Recept Signal Transduct Res. 2006;26(5-6):709-30. Review.

PMID:
17118807
18.

Indoles and related compounds as cannabinoid ligands.

Manera C, Tuccinardi T, Martinelli A.

Mini Rev Med Chem. 2008 Apr;8(4):370-87. Review.

PMID:
18473928
19.

Fungal biotransformation of cannabinoids: potential for new effective drugs.

Saxena S.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):305-12. Review. Erratum in: Curr Opin Drug Discov Devel. 2009 Jul;12(4):562.

PMID:
19333876
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk